BURLINGAME, Calif., Aug. 6, 2019 /PRNewswire/ -- Inflammatix, a molecular diagnostics company that is reimagining diagnostics, announced today that it has received the American Association for Clinical Chemistry's (AACC)

CHARLOTTESVILLE, Va., Aug. 6, 2019 /PRNewswire/ -- HemoShear Therapeutics, LLC, a privately held biotechnology company focused on discovering and developing drugs for metabolic disorders, today announced that Jim Powers, Chairman and CEO, will present at the 2019 Wedbush PacGrow Healthcare Conference. The presentation will take place on

MINNEAPOLIS, Aug. 6, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading physician-led, science-focused, multi-state cannabis company, today announced its participation at the 39th Annual Canaccord Genuity Growth Conference in Boston on

ANAHEIM, Calif., Aug. 6, 2019 /PRNewswire/ -- AACC 2019 – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is showcasing its latest instruments, assays and software for improving speed, accuracy and usability across clinical and research labs during the 71st American Association for Clinical Chemistry Annual Scientific Meeting an

DURHAM, N.C., Aug. 6, 2019 /PRNewswire/ -- Emergo Therapeutics has successfully completed their Phase 2a trial for their novel candidate norketotifen (NKT).  The trial is yet another step forward in addressing the symptoms of the flu and flu-like illness. The unique Phase 2a trial focused on using the immunomodulatory properties of NKT to treat symptom

PHILADELPHIA, Aug. 6, 2019 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX, "the Company") today announced that Michael F. Cola, President and Chief Executive Officer, will present at the 2019 Wedbush PacGrow Healthcare Conference on Tuesday, August 13, 2019 at 1:20 p.m. EDT

BOSTON, Aug. 6, 2019 /PRNewswire/ -- COTA, Inc., a healthcare technology company that uses real-world evidence (RWE) to bring clarity to cancer care, has announced its participation in a pilot program led by Friends of Cancer Research (Friends) focused on advancing the understanding and applications of RWE in oncology research.

ST. LOUIS, Aug. 6, 2019 /PRNewswire/ -- Bayer has awarded

PRINCETON, N.J., Aug. 6, 2019 /PRNewswire/ -- healtheo360, an online community of patients and caregivers with a network of over 30 million, has announced that Greg Byam has joined the company as Vice President, Business Development.With over 20 years of experience, Greg has devoted his career to leveraging innovative digital te

WESTBURY, N.Y., Aug. 6, 2019 /PRNewswire/ -- BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired Keystone Biologicals, Inc., a supplier of disease-state plasma, sera and controls, located in Hatboro, PA. This acquisition will expand BioIVT's disease-stat